- Pharmaceutical Technology's In the Lab eNewsletter 12-02-2020
- Volume 15
- Issue 12
Certara to Open New Office in China
The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry.
Certara, a US-based biosimulation company, is opening a new office in Shanghai, China’s Pudong District, a hub for biopharmaceutical research and development.
The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry, a Nov. 9, 2020 company press release said.
“We recognize the tremendous growth of China’s biopharmaceutical industry and are thrilled to have a direct presence in China so that we can fully support our rapidly growing Chinese customer base,” said William F. Feehery, PhD, CEO of Certara, in the press release. “Certara’s extensive experience in biosimulation and our partnerships with top global biopharmaceutical companies will help foster innovation in China, accelerate time-to-market for our customers, and most importantly, improve patient outcomes.”
Source:
Articles in this issue
almost 5 years ago
Intricate Modalities Need More Perceptive Adventitious Agent Testingalmost 5 years ago
Foxx Life Sciences Opens New Headquarters in Indiaalmost 5 years ago
Bio-Rad StarBright Dyes for Flow Cytometry Offer Enhanced Resolutionalmost 5 years ago
Nanoparticle Dissolution Testing Solution from Agilent Technologiesalmost 5 years ago
Enzo’s New Portable Microplate Reader Simplifies Laboratory WorkflowNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
